Rheumatology Author Dr Stanley Cohen: Fenebrutinib
Dr Stanley Cohen from Southwestern Medical School. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Stanley Cohen discusses a phase 2 trial o...
23 Jun 202012min
Discussing Rheumatology: Baricitinib Safety and Treatment Interruptions
Prof Iain McInnes discusses the safety profile and temporary interruption of baricitinib. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discus...
22 Jun 20208min
Insights at EULAR 2020: Safety Of JAK Inhibitors
Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on the safety of ...
17 Jun 202043min
Insights at EULAR 2020: Basic Science
Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great basic...
17 Jun 202017min
Insights at EULAR 2020: Clinical Data on JAK Inhibitors
Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on JAK inhibitors...
16 Jun 202045min
Insights at EULAR 2020: PRO & Real World
Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on patient report...
11 Jun 202032min
Insights at EULAR 2020: Beyond RA
Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on JAK inhibitors...
11 Jun 202032min
Insights at EULAR 2020: Day 4 Highlights
Prof Edwards presents the Day 4 highlights of the key abstracts and posters presented at EULAR 2020.
6 Jun 20207min
